Supplemental material
Journal of Medical Economics
Volume 27, 2024 - Issue 1
Mental Health
Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder
Jeff Scheina Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, USA
https://orcid.org/0009-0006-7892-5005
https://orcid.org/0009-0006-7892-5005, Martin Cloutierb Analysis Group, Inc., Montréal, Quebec, Canadahttps://orcid.org/0000-0002-4867-4739
https://orcid.org/0000-0002-4867-4739, Rebecca Bungayb Analysis Group, Inc., Montréal, Quebec, Canadahttps://orcid.org/0000-0001-7235-3292
https://orcid.org/0000-0001-7235-3292, Marjolaine Gauthier-Loiselleb Analysis Group, Inc., Montréal, Quebec, CanadaCorrespondence[email protected]
https://orcid.org/0000-0002-9439-595X
https://orcid.org/0000-0002-9439-595X & Ann Childressc Center for Psychiatry and Behavioral Medicine, Las Vegas, NV, USAhttps://orcid.org/0000-0001-5782-7891
https://orcid.org/0000-0001-5782-7891